1133 related articles for article (PubMed ID: 20429617)
1. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
2. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
Coimbra S; Oliveira H; Belo L; Figueiredo A; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2013 Feb; 14(1):49-53. PubMed ID: 23329079
[TBL] [Abstract][Full Text] [Related]
3. Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2012 Feb; 13(1):37-47. PubMed ID: 21888450
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
5. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
[TBL] [Abstract][Full Text] [Related]
6. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.
Chen X; Yang M; Cheng Y; Liu GJ; Zhang M
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009481. PubMed ID: 24151011
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free DNA levels in Portuguese patients with psoriasis vulgaris according to severity and therapy.
Coimbra S; Catarino C; Costa E; Oliveira H; Figueiredo A; Rocha-Pereira P; Santos-Silva A
Br J Dermatol; 2014 Apr; 170(4):939-42. PubMed ID: 24245854
[TBL] [Abstract][Full Text] [Related]
8. Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis.
Romaní J; Caixàs A; Carrascosa JM; Ribera M; Rigla M; Luelmo J
Br J Dermatol; 2012 Jun; 166(6):1237-44. PubMed ID: 22309899
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of UV-based therapy for psoriasis.
Almutawa F; Alnomair N; Wang Y; Hamzavi I; Lim HW
Am J Clin Dermatol; 2013 Apr; 14(2):87-109. PubMed ID: 23572293
[TBL] [Abstract][Full Text] [Related]
11. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
Beani JC; Jeanmougin M
Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive lipid tetrad index, atherogenic index and lipid peroxidation: Surrogate markers for increased cardiovascular risk in psoriasis.
Sunitha S; Rajappa M; Thappa DM; Chandrashekar L; Munisamy M; Revathy G; Priyadarssini M
Indian J Dermatol Venereol Leprol; 2015; 81(5):464-71. PubMed ID: 26323680
[TBL] [Abstract][Full Text] [Related]
13. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
[TBL] [Abstract][Full Text] [Related]
14. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB.
Akman A; Dicle O; Yilmaz F; Coskun M; Yilmaz E
Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):123-7. PubMed ID: 18477130
[TBL] [Abstract][Full Text] [Related]
15. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
Karrer S; Eholzer C; Ackermann G; Landthaler M; Szeimies RM
Dermatology; 2001; 202(2):108-15. PubMed ID: 11306830
[TBL] [Abstract][Full Text] [Related]
16. Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris.
Werfel T; Holiangu F; Niemann KH; Schmerling O; Lüllau F; Zedler A; Sträter HD; Niebuhr M
Br J Dermatol; 2015 Mar; 172(3):746-53. PubMed ID: 25307476
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):789-96. PubMed ID: 20002653
[TBL] [Abstract][Full Text] [Related]
18. Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
Caca-Biljanovska NG; V'lckova-Laskoska MT
Croat Med J; 2002 Dec; 43(6):707-12. PubMed ID: 12476481
[TBL] [Abstract][Full Text] [Related]
19. Narrowband ultraviolet B versus psoralen plus ultraviolet A therapy for severe plaque psoriasis: an Indian perspective.
Chauhan PS; Kaur I; Dogra S; De D; Kanwar AJ
Clin Exp Dermatol; 2011 Mar; 36(2):169-73. PubMed ID: 20545955
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the length of remission of psoriasis vulgaris.
Coimbra S; Oliveira H; Figueiredo A; Rocha-Pereira P; Santos-Silva A
Clin Drug Investig; 2013 Nov; 33(11):855-60. PubMed ID: 23982521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
